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1. ABSTRACT  
En este trabajo se ha realizado un estudio de la radioterapia FLASH tanto de forma teórica 
como de manera experimental. En primer lugar, el trabajo se centra en un estudio 
bibliográfico del estado del arte de la radioterapia FLASH. En segundo lugar, particularizando 
para protonterapia FLASH, se ha llevado a cabo la dosimetría de un experimento preclínico 
realizado por el Grupo de Física Nuclear (GFN) de la Universidad Complutense de Madrid 
(UCM). En este experimento distintas muestras fueron expuestas a protones de 3 MeV 
mediante irradiación FLASH y convencional. La dosimetría de dicho experimento, realizada 
en este trabajo, se lleva a cabo empleando películas radiocrómicas.  En el proceso de 
dosimetría se ha realizado una calibración de las películas radiocrómicas que permite la 
posterior obtención de la dosis impartida a las distintas muestras del experimento. Además, 
las radiocrómicas también se han empleado para realizar medidas del perfil del haz. A su vez, 
se ha llevado a cabo un estudio teórico de la respuesta de las radiocrómicas en función del 
LET (transferencia lineal de energía) de los protones, concluyendo que estas realizan una 
subestimación de la dosis en las proximidades del pico de Bragg debido al efecto de 
quenching, Este estudio teórico se ha comprobado mediante los resultados experimentales 
obtenidos de las medidas de perfiles del haz y una simulación de Monte Carlo realizada con 
TOPAS. 
In this work FLASH radiotherapy has been studied in a theoretical and experimental way. 
First, this work is based on a bibliographic research of the current state of the art. Secondly, 
the study is particularized on FLASH protontherapy. In this second part of the work, I 
conducted the dosimetry of a preclinical experiment made by the Group of Nuclear Physics 
(GFN) of Universidad Complutense de Madrid (UCM). In this experiment different samples 
were exposed to 3-MeV protons delivered with FLASH and conventional irradiation rates. 
The dosimetry of the experiment was performed with radiochromic (RC) films. This process 
required a prior calibration of the RC film to allow measurement of absolute dose during the 
experiment. The experiment also included characterization of the beam lateral spread. 
Furthermore, we conducted a theoretical study of the RC film dose response as a function of 
the linear energy transfer of protons, concluding that RC films show a dose under response in 
the proximity of Bragg peak (quenching effect). This theoretical study was verified with the 
measured beam profiles and a Monte Carlo simulation using TOPAS. 
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2. FOREWORD 
FLASH radiotherapy is an emerging radiotherapy technique whose potential as a future 
treatment against cancer is being investigated by several researchers. The Nuclear Physics 
Group (GFN) of Universidad Complutense de Madrid (UCM) is conducting FLASH 
protontherapy preclinical experiments, whose purpose is to evaluate biological parameters 
which describe the response of tumour and healthy cells after FLASH and normal irradiation. 
These experiments are taking place in the Center for Microanalysis of Materials (CMAM), a 
research centre located in Universidad Autónoma de Madrid (UAM) which has an 
electrostatic ion accelerator.  
In particular, this work is focused on the experiment I attended, in which different samples 
were irradiated with 3-MeV protons at conventional and FLASH dose rates. Irradiated 
samples were classified into three groups: normal living cells, tumor cells and normal cells 
associated to tumor. In order to irradiate correctly the samples of interest and evaluate the 
results, an appropriate dosimetry is needed. In the preclinical experiment carried out in 
CMAM, radiochromic films were used as dosimeters, and this work is focused on this 
dosimetry process. 
In order to extract dose information from RC films, a thorough process must be followed. 
First, it is necessary to perform a calibration, a relation between the dose delivered by the 
accelerator and the optical density of the film (when the film is irradiated it gets more or less 
dark depending on the delivered dose). Doses delivered during calibration were estimated 
from known beam intensity and shutter opening times, convoluted with known beam sizes, 
energy and stopping power at irradiation position. Once calibration curve is calculated, 
absorbed dose by the samples can be extracted from the radiochromic films darkening. 
On the other hand, radiochromic films were also employed in the experiment to carry out 
measurements of the beam profile. This is used to characterize in-air spread of the beam 
(which ultimately depends to the beam optics configuration) and it is used by the treatment 
planning system to calculate adequate shutter times in order to deliver the required doses, 
taking into account the air distance traveled by the beam before hitting the target. 
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3. FLASH RADIOTHERAPY 
3.1 INTRODUCTION 
Nowadays, radiotherapy is one of the main treatments against cancer. Its aim consists in 
eradicating tumors while protecting as much as possible the surrounding normal tissues. 
Throughout the years, clinical radiotherapy treatments have experimented different 
improvements in order to achieve this objective. For example, treatments have been 
fractionated so that patients are exposed to 1.8-2 Gy per session instead of receiving the total 
dose in a single session, this way side effects in healthy tissues are reduced. Furthermore, 
technology development has allowed optimizing the irradiated volume, reducing the body 
region which is going to be exposed to radiation.  
In the recent years, a different factor is being taken into account in order to protect normal 
tissues, irradiations with ultra high dose rates. This way, total dose can be delivered in ms 
and, consequently, treatment duration is notably shortened. This modality is named FLASH 
radiotherapy, an emerging technique which employs dose rates 100 times higher ( > 40 Gy/s) 
than the ones utilized in conventional radiotherapy ( 0.03 Gy/s). FLASH radiotherapy 
potential is currently being investigated and, although further research is needed, different 
preclinical experiments, employing FLASH irradiation, have shown a protective effect in 
healthy tissues while maintaining the antitumor efficiency. This reduction of normal tissues 
damage is named FLASH effect. 
The biological reasons why the protective effect is observed have been investigated by several 
researchers, and different hypothesis have been proposed. Some of the theories are based on 
the fact that tissues with low oxygen concentration are more resistant to radiation than well 
oxygenated tissues (Pratx, 2019) (Montay-Gruel, 2019). A particular study consisted in 
investigating the impact of FLASH and conventional irradiation in mice memory as a 
function of oxygen concentration in the brain and free radicals production (Montay-Gruel, 
2019). It was hypothesized that ultra high dose rate irradiation reduce the production of free 
radicals through a fast depletion of oxygen concentration (high concentration of free radicals 
cause damage in DNA, cellular structures, etc, it favors carcinogenesis). To test this theory, 
brain oxygen concentration in mice was doubled (breathing carbogen), and it was shown that 
the increase in oxygen concentration implied the loss of the neurocognitive benefits 
previously observed with FLASH irradiation. Furthermore, the production of      (a type of 
toxic free radical resulted from radiolysis) was measured and a notably lower concentration of 
     with FLASH irradiation compared to conventional irradiation was obtained. It can be 
concluded as a possible biological explanation that FLASH radiotherapy benefits depend on 
local oxygen concentration and free radicals production. 
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3.2 CURRENT EVIDENCE FOR FLASH RADIOTHERAPY 
While the first works on high dose-rate effects in radiotherapy date back from more than four 
decades ago (Dewey, 1969), this effect was re-discovered in 2014 (Fauvadon, 2014) and has 
since then gained enormous momentum. A number of in-vitro and in-vivo preclinical studies 
have been reported and finally, in early 2019, the first patient was treated in a Swiss hospital 
(Bourhis, 2019). 
In this section, seven preclinical experiments and a clinical treatment are described. Six of 
them are in-vivo preclinical trials, while only one reports findings based on in-vitro cell 
cultures. More than 70% of the analyzed experiments support the advantages of FLASH 
radiotherapy versus standard-rate radiotherapy. 
3.2.1 IN-VIVO PRECLINICAL STUDIES 
Fauvadon et al (Fauvadon, 2014) performed the first in-vivo experiment to explore the 
potential of ultra-high dose rate irradiation in radiotherapy. In order to evaluate the potential 
of FLASH, it was analyzed the effect of FLASH and conventional-rate electrons in terms of 
tumor control and related complications, such us, development of pulmonary fibrosis and the 
occurrence of apoptosis (a form of cell death) in mice. 
Related to the study of lung fibrosis, mice were irradiated with 17 Gy at FLASH (60 Gy/s) 
and conventional (0.03 Gy/s) dose-rates, as well as with 30 Gy in FLASH mode. The results 
reported that mice exposed to 17 Gy-CONV showed initial signs of fibrosis 8 weeks post-
irradiation, and 24 weeks later massive fibrotic lesions were observed. In the 17 Gy-FLASH- 
group fibrosis was not observed, and 24 weeks after, only a few of the mice exposed to 30 
Gy-FLASH developed fibrotic patches. FLASH radiotherapy seemed to be less fibrogenic 
than conventional radiotherapy. Additionally, tumor growth was followed by 
bioluminescence analysis (Fig 1).  
Tumor growth in the control group was fast and, as a consequence, individuals had to be 
euthanized. There were two 15-Gy-CONV survivors cured, but they presented fibrotic 
remodeling. In contrast, there were seven 28-Gy-FLASH survivors, most of them tumor-free, 
and they did not present initiation of fibrosis. 
Overall, their results determined that FLASH improved the differential response between 
normal tissue and tumor, preventing side effects and controlling the tumor. This experiment 
had a high relevance and motivated more researchers to investigate further into the FLASH 
effect. 
The protective effect of FLASH on normal tissues, specifically on brain tissues, was studied 
in different occasions in the recent years. In 2017, the preservation of memory and 
neurogenesis (birth of new neurons) in mice hippocampus after whole brain irradiation, using 
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electron beams, was investigated (Montay-Gruel, 2017). And it was concluded that damage to 
normal-brain tissue could be reduced by increasing the dose rate. One year later, another in-
vivo experiment was designed to assess whether the previous results could be reproduced 
with X rays generated by a synchrotron (Montay-Gruel, 2018). And protection of normal 
tissue with FLASH irradiation was also observed. 
 
Fig 1. Lung tumor evolution in three different groups: control (0 Gy), mice exposed to 15 Gy at conventional 
dose rate, and mice exposed to 28 Gy at FLASH rate. Tumor cells were implanted on day D, and two days later 
mice were treated (Fauvadon, 2014). 
Furthermore, in 2019, studies in mice were extended to demonstrate efficacy of FLASH 
radiotherapy in mini-pig and cat patients (Vozenin, 2019). Two prototypes of linear 
accelerators, for producing electron beams, were designed. The aim of the study was to 
evaluate if the differential effect between tumor and normal tissue could also be observed in 
higher mammals. 
In first place, skin patches on the back of the pig (Fig 2) were irradiated with doses ranging 
from 22 to 34 Gy at standard and FLASH dose rates. 32 weeks after delivering 28-34 Gy at 
conventional dose rate, depilation and fibrosis was observed. While, after the same time post 
irradiation (32 weeks) and the same delivered dose (28-34 Gy), at FLASH dose rates, not only 
fibrosis was not observed but also hair was regrowing. These results confirmed that FLASH-
RT is a non-fibrosing modality (it does not produce the formation of excess fibrous tissue in 
an organ or tissue in a reparative process) compared to conventional-RT. It motivated the 
researchers to perform a dose-escalation FLASH-RT clinical trial where six cats with 
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squamous-cell carcinoma of the nasal planum were treated with radiotherapy in a single 
fraction.  
 
Fig 2. Skin patches on the back of the pig 36 weeks after being irradiated at conventional and FLASH mode 
(Vozenin, 2018). 
Their results reported a remarkable normal tissue tolerance to the high single dose and a high 
tumor control rate (Fig 3). Five out of six cats experienced the disappearance of all clinical 
evidence of tumor. This study is an important contribution for the possible translation of 
FLASH radiotherapy to clinical practice. 
A    B    C  
Fig 3. Evolution of the lesion in cat nᵒ2 over time. A- Before radiotherapy, B- 7 months post FLASH 
radiotherapy, C- 14 months post FLASH radiotherapy (Vozenin, 2019). 
Up to now, in-vivo experiments which demonstrate FLASH effect generated by photon and 
electron beams have been mentioned. But, in recent years, researchers have also made studies 
related to proton FLASH irradiation. 
In 2019 the first in-vivo study of the proton FLASH effect was published (Beyreuther, 2019). 
However, the results did not show the expected protective effect on normal tissue.  
In the experiment Zebrafish embryos were irradiated at conventional (5 Gy/min) and FLASH 
(100 Gy/s) dose rate with a proton beam. To evaluate the potential of proton FLASH therapy, 
embryonic survival, pericardial edema as acute radiation effect and parameters indicators of 
morphological malformations were analyzed. The results concluded that there was no 
difference in the response of embryonic survival and malformations between the embryos 
irradiated at FLASH and conventional dose rates. The only result that supported the FLASH 
protective effect was the rate of pericardial edema, which was lower when dose was delivered 
at FLASH dose rates compared to conventional dose rates.   
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3.2.2 IN-VITRO PRECLINICAL STUDIES 
In 2019, an in-vitro experiment was published (Buonano, 2019). In it a FLASH dose rate 
proton machine was used to irradiate normal human lung fibroblasts. The aim of the study 
was to analyze acute and long term irradiation induced effects in normal cells. 
On one hand, positive results respecting FLASH protective effect were obtained. It was 
observed that ultra-high dose rates improved inflammatory markers responses. But, on the 
other hand, the results of the evaluation of DNA damage and normal cell survival as a 
function of dose rate, did not supported the FLASH protective effect. Irradiating cells at 
higher dose rates did not reduce DNA damage, and it did not increased normal cell survival. 
Both proton therapy studies, in vivo (Beyreuther, 2019) and in vitro (Buonano, 2019) 
obtained contradictory information about FLASH protective effect on normal tissue. 
3.2.3 FIRST PATIENT TREATED WITH FLASH RADIOTHERAPY 
Positive results of most of preclinical experiments were the base to consider FLASH 
radiotherapy as a promising option for a patient with cutaneous lymphoma. This patient was 
75 years old, and his illness had been treated with nine different treatments over 18 years. As 
none of them was able to control the disease, it was disseminated throughout the skin surface 
(Fig 4).  
 
Fig 4. Tumor sites over the skin of the patient (Bourhis, 2019). 
Due to the good differential response between normal tissue and tumor offered by FLASH 
therapy, it was considered as a good option to treat one of the most resistant lesions of the 
patient. The first treatment of a human with FLASH radiotherapy was carried out in 2019 
(Bourhis, 2019). The device used to deliver an electron beam in FLASH modality was a linac 
prototype, Oriatron eRT6 5.6-MeV. 
The dose prescribed for the treatment was 15 Gy given in 90 ms. This decision was taken by 
the researches after studying the results obtained in previous pre-clinical experiments, such as 
(Vozenin, 2019). To ensure 15 Gy was exactly the dose delivered on the lesion, dose profiles 
were measured with GafChromic films before and after the irradiation. 
The results showed that tumor started to diminish 10 days post irradiation, a rapid response, 
and it was completely eradicated at 36 days. On the other hand, skin reactions appeared, but 
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they were minor reactions compared to previous ones after exposure to prior treatments. In 
conclusion, positive results regarding tumor control and normal tissue were obtained. 
This first patient treatment demonstrated the feasibility of FLASH radiotherapy for clinical 
application. 
3.3 DOSIMETRY  
In every radiotherapy treatment or irradiation one of the main parts of the process is the 
dosimetry. Prior to any irradiation it is really important to make dose measures and check that 
the dose which is going to be delivered follows the planned conditions. For example, 
checking that the correct amount of Grays is delivered and which regions of the patient body 
or sample are going to be exposed to that dose. Dosimeters are the instruments employed to 
conduct these dose measures. 
As it was explained in the foreword of this work, Nuclear Physics Group (GFN) carried out a 
preclinical FLASH protontherapy experiment at CMAM facility. The aim of the experiment 
was to investigate the potential of FLASH protontherapy comparing the different samples 
response after FLASH and conventional irradiation. The dosimeters employed in this study 
were radiochromic films, and in the next sections it is going to be explained the whole 
dosimetry process. 
4. RADIOCHROMIC FILMS FOR PROTON DOSIMETRY 
Radiochromic films are chemical passive dosimeters. When these films are irradiated 
chemical reactions are induced, in particular, polymerization reactions. RC films material is 
presented as monomers, when dose is delivered these monomers are joined forming polymers 
(longer chains) and, consequently, film optic properties are altered. This process is due to the 
activity of free radicals generated by radiation. In particular, the materials which produce the 
coloration of the film are crystalline polyacetylenes (Das, 2017, 373), when they are exposed 
to radiation polymerization takes place and film darkening is visualized. The higher the dose 
delivered is, the darker the film gets. This way, the absorbed dose by the film can be known 
from the variation of its optical density (OD).  
4.1 CURRENT STATE OF THE ART 
Radiochromic films have been employed as radiation dosimeters since 1960, although not for 
clinical use. In mid-1980s, the radiochromic film known as GAFchromic was produced by the 
International Specialty Products (ISP) (Das, 2017, 373). Several radiochromic film types have 
been developed by different manufacturers along the years, so this section is going to focus on 
the available GAFchromic RCF products which have useful dose ranges for clinical 
radiotherapy applications.  
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In 2004, EBT film was introduced, a more sensitive radiochromic film model than previous 
ones. Five years later, EBT films were replaced by EBT2 films which have the same active 
component as the EBT but it has a single active layer (the sensitive material to radiation). 
EBT2 films have a type 2 configuration shown in Fig 5. In order to eradicate the dependence 
on which side of the film faces the light source of a scanner or the radiation source, EBT3 
films were introduced. In both EBT2 and EBT3 films, the active layer is protected by two 
polyester layers, however EBT3 have a symmetric configuration (type 3 configuration in Fig 
5). 
 
Fig 5.  Radiochromic film type 1, type 2 and type 3 configurations (Das, 2017, 373). 
The most interesting radiochromic film configuration for this work is type 1, unlaminated 
EBT3 films. These films were the ones utilized in the CMAM experiment whose dosimetry is 
made in next sections. As the beam energy of the experiment was low (3 MeV), protons range 
in material is short and would otherwise be stopped in the film substrate, not reaching the 
active layer. So we employed unlaminated EBT3, a EBT3 model in which the upper polyester 
layer has been removed.  
The use of radiochromic films as reference dosimeters for radiotherapy or preclinical 
experiments provides some advantages and disadvantages. These films offer a near-tissue 
equivalence and a submillimetric spatial resolution, however, RC films can be damage if they 
are exposed to high temperatures (>60ºC) or to room light. 
Scientists have experimentally studied RC films suitability for complex radiotherapy 
dosimetry in the recent years. In particular, interesting results for low energy protons were 
obtained in an experiment conducted in 2015 (Reinhardt, 2015). Dose response curves of 
EBT2 and EBT3 films for 20 MeV protons and 6 MeV photons were compared and no 
significant difference was observed. However, an under response was visualized in the 4 MeV 
protons dose response curve, in the proximity of the Bragg peak. This low-energy effect with 
protons (quenching effect) will be studied in the section 4.3.2. If this effect is taken into 
account RC films can be used as reference dosimeters for low energy proton measures. 
Furthermore, in 2017, it was demonstrated that EBT3 films response is energy and mean 
dose-rate independent (Jaccard, 2017). In that investigation a clinical radiotherapy linac 
(Eleka Synergy) and a prototype high dose-rate linac (Oriatron eRT6) were employed to 
deliver electron beams. EBT3 films suitability for high dose-rate measurements was 
confirmed. 
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4.2 METHODOLOGY 
In the experiment performed at CMAM, radiochromic films were employed as dosimeters for 
FLASH protontherapy. The aim of its use was to verify that the dose absorbed by the 
irradiated sample and the planned dose corresponded. The films employed were unlaminated 
EBT3 (lot 11181901P1). 
Films were placed at the end of the beam and perpendicular to the direction of the beam axis, 
in the same conditions in which samples would be irradiated later. As unlaminated EBT3 
films have an asymmetric configuration, care was taken ensuring that the same film side was 
facing the beam exit. Films were irradiated with a 3 MeV proton beam. Subsequently, they 
were scanned. It is important to wait at least 12 hours between exposure and digitalization 
because of the change of the optical density, films continue getting darker after exposure. In 
particular, the ones used for calibration were scanned 12 hours after irradiation. The scanner 
(HP Scanjet G3110) was employed in transmission mode. Each film was cut into three pieces 
before scanning because of the scan window dimensions. 
 Another aspect to take into account is the position and the orientation of the film on the 
scanner. The scanner response changes depending on how near to the scanner axis the film is 
(Micke, 2011), lateral artifact effects are minimized if the film is positioned along the central 
axis and parallel to the scan direction. Furthermore, all films were scanned positioning the 
most sensitive side of the film on the scanner. 
4.3 RESULTS 
4.3.1 PREPARATION OF RADIOCHROMIC FILMS 
4.3.1.1 RADIOCHROMIC FILM CALIBRATION 
In order to obtain the dose delivered to the film, a calibration curve is needed, a relation 
between dose and optical density, OD, (film darkening). Although higher levels of dose 
induce higher values of OD, this relation is not usually linear. Several calibration curves have 
been utilized by the authors of different studies conducted in the recent years.  
The method which is going to be employed to evaluate radiochromic film dosimetry is a 
multichannel film dosimetry method. The scanner used for digitizing films is a multichannel 
one, it consists of three channels: red (R), blue (B) and green (G)). Optical density obtained 
from the three different channels will allow distinguishing between the part of the film 
response that depends on the dose delivered and the part of the film response that is dose 
independent. This second part will inform about film imperfections like active layer thickness 
variations. 
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First of all, calibration films were irradiated with a plan that delivers twelve radiation pulses 
in a dose range from 1 Gy to 12 Gy, Fig 6.  
 
Fig 6. Radiochromic film employed for calibration. 
Where 65535 is the maximum pixel value (16-bit TIF format was used), and each channel 
provides a different value of OD (as it is observed in Fig 7). Subsequently, calibration curve 
can be obtained, dose (D) and OD are fitted according Eq.1 from Micke et al. 2011. It is 
represented in Fig 7.  
OD =     
     
   
                                                     (1) 
 
Fig 7. Multiple channel calibration curves. 
It must be pointed out that calibration curves perfectly agree with each channel OD values. Fit 
parameters are given in Table 1. 
Table 1. Calibration curve parameters (Eq.1) for each channel. 
Channel a b c 
R 2.44539 0.03703 3.05876 
G 4.38756 -0.04446 5.67209 
B 13.55192 -0.19617 23.59271 
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4.3.1.2  LEAST SQUARES METHOD FOR DOSE CALCULATION 
As a triple-channel film dosimetry method is being used, the scanned optical density can be 
separated in two different parts, the dose dependent one and the optical density on account of 
disturbances such as variation of the film active layer thickness. If these two parts are not 
distinguished, film imperfections could lead to erroneous dose values.  
The dose value given by each channel can be calculated following Eq.2. Where Eq.2 has been 
estimated solving the dose, D, from Eq.1, and including the disturbance, active layer thickness 
variations, in the optical density term (multiplying OD·∆d). ∆d is defined as    
 
 
 where   
is the active layer thickness and   the average film thickness.  
    
             
           
                                                          (2) 
Each channel provides different dose values,   ,    and   . The difference between these 
dose values,  , is minimized employing a least square equation, Eq.3.   has to be minimized  
because the dose can not depend on the chosen channel. 
         
         
         
                                (3) 
The values of the disturbance parameter, ∆d, were chosen in the range from 0.8 to 1.2. Final 
value was selected so that is minimum, 
    
     
  . ∆d values corresponding to the minimum   
value for each pixel will determine the dose independent part of the film response 
(disturbance map). Therefore,   ,    and    are calculated for these disturbance values 
following Eq.2. Subsequently, the final measured dose is obtained as the average of   ,    
and   , Eq.4. 
           
        
 
                                                  (4) 
Figure 8 (left side) shows the scanned image of an unlaminated EBT3 film exposed to 2 Gy. 
That figure (right side) also shows the simulation of the radiochromic film, how the non 
irradiated film would look like if it did not have any imperfection.  Furthermore, the dose 
map, whose dose values have been calculated using Eq.4, and the disturbance map are 
represented in Fig 9. The scanned film shows some inhomogeneities like dust particles in the 
centre of the image. These imperfections are also observed in the disturbance map, however, 
the dose map is homogeneous. Triple-channel method has separated the dose independent part 
of the film response (disturbance map), from the dose dependent part (dose map). 
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Fig 8. EBT3 film exposed to 2 Gy (left image) and the non irradiated radiochromic film (right image). 
  
Fig 9. Dose map and disturbance map for the scanned film shown in Fig 8. 
4.3.2 QUENCHING THEORETICAL STUDY  
Radiochromic films response in different conditions has been investigated by several 
researchers. From the different experiments, the energy independence of films response was 
confirmed with an exception, films exposed to low energy proton beams. In that case, 
radiation induced optical density values lower than it should be in the proximity of the Bragg 
peak. This film under-response is named quenching effect.  
There are two hypothesis to explain quenching effect (Grilj, 2018). On one hand, in the film 
crystal lattice, polymerization sites are spaced with some separation. High LET radiation 
could activate the polymerization of all sites in the neighborhood of a single ionizing particle 
track. This way, there is a moment in which all polymerization sites are activated and the film 
is saturated. In that conditions although the film is exposed to additional radiation it is not 
going to induced more polymerization or film darkening, so dose values extracted from the 
optical density will be lower than the real dose absorbed by the film. On the other hand, it 
exists the possibility that high-LET radiation generates fewer polymerization than low-LET 
radiation. The reason would be that high LET particles could lead to the formation of a higher 
density of free radicals and, consequently, they could recombine without initiating 
polymerization. Fewer polymerization imply fewer film darkening. 
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The aim of this section is to show quenching effect employing LET values obtained from 
NIST website and calculations developed in a Matlab program. If initial particles energy (3 
MeV) and travelled distance (20 cm) are introduced, then the Matlab code obtains particles in-
water stopping power of particles at the position of the RC film. This way, 3 MeV protons 
employed in CMAM experiment were simulated. In order to quantify the dose under-response 
or quenching effect, we employed the relative efficiency (RE) parameter. Researchers have 
utilized similar RE definitions, for example Reinhardt et al (Reinhardt, 2015) define it as the 
range of dose values that, deriving from different beam energies, lead to the same film 
response. Each researcher utilizes a different relation between LET and RE, as Reinhardt et al 
used 4 MeV protons in their study its RE expression, equation (5), was used to calculate RE 
values corresponding to our 3 MeV protons. 
RE = 100% - a·LET·b                                                  (5) 
Where a and b are fit parameters. However, this expression was not suitable for our 3 MeV 
protons, LET values were so high that negative RE values were obtained. We needed a RE 
expression appropriate for high LET particles. In 2018, a study was published in which RC 
films response was investigated with MeV ions beams (Grilj, 2018) and a modified RE 
expression was shown, equation (6). In this equation the LET dependence of the film response 
was introduced in the parameter    , which is the dose corresponding to one half of the 
maximum optical density (maximum film darkening).  
    
  
 
   
  
 
     
 
  
 
   
        
 
   
                                              (6) 
         represents the infinitesimally small LET value. It can be considered as the      
corresponding to low LET radiation, for example, photon beams. Due to the proximity 
between the data utilized in this study (low energy protons and ions, and high LET range) and 
the data employed in our simulation, the parameter         = 45 Gy was taken from Grilj et 
al study. In order to obtain the slope ‘a’ of the linear relation between      and LET and its 
uncertainty, the bootstrapping method was applied. The practice of bootstrapping basically 
consists in estimating the uncertainty of a parameter (a) from two variables with its respective 
uncertainties (LET and     ). Employing LET and      values provided in the study, with 
Matlab help, we generated random points inside the Gaussian distributions centered at      
and       with standard deviations       and       . This way each coordinate (LET,     ) 
was calculated several times and in each iteration a linear regression was made, obtaining the 
slope ‘a’     times. This way the mean and the standard deviation of all ‘a’ values resulted in 
     = (0.4960  0.0576) 
  
   
. 
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Introducing LET values in equation (6) the relative efficiency was calculated and, 
consequently, quenching effect can be evaluated. Fig 10 shows how RE decreases when LET 
increases. Meaning that the higher the LET, the higher the difference between the dose 
delivered to the film and the dose measured from the film: quenching effect increases with 
LET. In addition, Fig 11 clearly shows that this effect takes place in the proximity of Bragg 
peak. If both graphics in Fig 11 are compared, a notable decrease in RE is observed at the 
distance where Bragg peak is. 
On the whole, quenching effect has been theoretically demonstrated and, as a consequence, it 
can be concluded that RC films response has a high dependence on the beam exit – RC film 
distance. In Fig 11 it can be seen that RC film is less efficient when the distance increases, so 
this effect has to be taken into account when RC films are employed as dosimeters for 
irradiation with high LET particles. 
 
Fig 10. Relative efficiency as a function of LET. RE error was calculated as a consequence of parameter ‘a’ 
uncertainty (blue bands). Relative errors are less than 6%. 
4.3.3 DOSIMETRY FOR SAMPLE IRRADIATION 
In the CMAM experiment different samples were irradiated, in particular breast cancer cells 
and fibroblasts. Cells were contained in wells and plates, with circular and rectangular shape 
respectively. The aim of samples irradiation was to deliver the same dose with FLASH dose 
rates and with conventional dose rates, and observing cells response after both irradiation 
modes. In order to check the dose delivered to the cells in each mode, radiochromic films 
were employed. Unlaminated EBT3 films were exposed to the same irradiation plans as 
samples.  
In the case of well dosimetry, results are shown in table 2, where dose measures have been 
obtained for circular regions with well radius. If doses obtained with FLASH and 
conventional irradiation are compared, it can be seen that both groups of values are similar 
with the exception of the two highest doses delivered (shots 5 and 6), whose values differ in 1 
and 2 Gy from FLASH to conventional mode. 
 
18 
 
 
 
Fig 11. Water Bragg peak for 3 MeV protons (up), and the relative efficiency as a function of  LET and traveled 
distance (down). RE error was calculated as a consequence of parameter ‘a’ uncertainty (blue bands). 
Table 2. Dose measured from RC films utilized for wells dosimetry. 
 
   FLASH 
 
CONVENTIONAL 
Shot number D (Gy) ∆D (Gy) D (Gy) ∆D (Gy) 
1 1.3987 0.0278 1.1497 0.0077 
2 1.8706 0.0697 1.999 0.0716 
3 3.7009 0.1439 3.1946 0.0934 
4 5.4932 0.3644 5.9219 0.0818 
5 11.1675 0.3708 10.5119 0.3685 
6 16.5965 0.5106 14.5874 0.2856 
Furthermore, results obtained for cells contained in plates are shown in Fig 12 (after FLASH 
irradiation) and Fig 13 (after conventional irradiation). In them, dose distribution and dose 
histograms for each irradiated region of the RC film are shown. These dose measures have 
been calculated for rectangular regions with plate dimensions. The fact that the scanned RC 
film might be rotated a certain angle with respect to the horizontal scanner axis has also been 
taken into account.  
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If figures 12 and 13 are compared, it can be seen that dose delivered with FLASH and 
conventional dose rates is not the same. The unlaminated EBT3 film exposed to FLASH 
irradiation received higher dose values than the one exposed to conventional dose rates, 
probably due to fluctuations in beam current or an incorrect estimation of beam size and 
shape at the irradiation position. 
 
Fig 12. FLASH irradiation results. Dose maps for each spot (left side) where the color bar indicates a dose range 
from 0 to 10 Gy. In the right side its corresponding dose histograms are shown. 
 
Fig 13. Conventional irradiation results. Dose maps for each spot (left side) where the color bar indicates a dose 
range from 0 to 10 Gy. In the right side its corresponding dose histograms are shown. 
4.3.4 BEAM PROFILE MEASURES IN AIR AND QUENCHING VERIFICATION 
Unlaminated EBT3 films were also utilized for beam profile measurements. These were 
conducted with and without pepperpot, a pinhole filter used to reduce the beam intensity for 
certain experiments. Measurement process consisted in irradiating different spots of the film 
while the distance between the film and the beam exit increased. Initial film-beam exit 
distance was 4.9 cm and it increased 1.5 cm between each spot irradiation. This process was 
repeated twice for each film, delivering low and high dose on the RC film spots. In the second 
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part of the irradiating process the number of FLASH shots delivered in each spot of the film 
was higher. The visual result of the whole irradiating plan is shown in Fig 14. 
  
Fig 14. Unlaminated EBT3 film exposed to the measuring beam profile irradiation plan. In the left image  
pepperpot was not employed, while in the right image it was used.  
In the case in which pepperpot is not used, in the first part of the irradiating process (columns 
1 and 2 of Fig 14 (left side)) 2 FLASH shots were delivered in each film spot, and in the 
second part (columns 3 and 4) higher dose was utilized, 6 FLASH shots in each spot. The 
duration of each shot duration was 0.75 ms. Furthermore, when irradiation was carried out 
with pepperpot (Fig 14 (right side)), low dose spots where exposed to radiation during 50 ms 
and high dose spots during 250 ms. 
The followed process to obtain the profile measurements was the same for both irradiation 
modes (with and without pepperpot). Unlaminated EBT3 films were exposed to high doses 
(       and low doses (    ), where 
     
    
  . The objective is to employ the information 
provided by both spot types (high and low doses) to measure the dose central value and the 
beam width (σ) as a function of the distance. Considering that high dose spots saturate (its 
darkening is maximum) at the centre of the region, they will just provide correct information 
about the periphery of the spots. However, low dose spots will inform correctly about the 
central region. This is the reason why the best option is to integrate both spots types 
information. In order to integrate that information, low doses are multiplied by the factor x so 
that high and low doses are equalized. Then, for each pixel, the maximum value between 
      and        is chosen and employed in the final dose distribution. From this final dose 
distribution    and    are obtained (beam width in x and y axis).  
The dose value in the central point of each spot and the beam width (   and   ) are 
represented as a function of the air distance traveled (z) in Fig 15. It should be pointed out 
that the relation between σ and z follows a second grade polynomial (fit parameters are given 
in Table 3). The longer the traveled distance is, the wider the beam gets and the lower the 
central dose is. Dose values with pepperpot are higher than without pepperpot due to the fact 
that when the filter is used, beam intensity is reduced but exposure time is increased. 
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Fig 15. (Left side) Dose at the centre of each spot as a function of the air distance traveled for both irradiation 
modes, with and without pepperpot. (Right side) Beam width in x and y axis as a function of the air distance 
traveled. Second grade polynomial fit parameters are shown in table 3. 
Table 3. Fit parameters for the second grade polynomial relation between beam width and traveled distance.  
 
                              y = a·   + b·x + c 
 
  
a b c 
Without pepperpot sigma x 0.0024 0.2840 -0.3522 
 
sigma y -0.0008 0.3415 -0.5623 
With pepperpot sigma x -0.0080 0.3642 -0.0846 
 
sigma y -0.0055 0.3088 0.0896 
In order to check if there is an under response (quenching effect) in the dose central measures, 
experimental dose measures (without pepperpot) were compared with the ones obtained by 
estimating the average LET with a Monte Carlo simulation in TOPAS and using expression 6 
(Grilj, 2018) to determine the expected RE. Fig 16 shows the tendency of both groups of dose 
values normalized to the first point. In this figure it can be seen that experimental values are 
lower than simulated ones, there is a dose under response in RC films measures, a quenching 
effect. Illustrative quenching measures can be given by relative efficacy (RE) calculation, 
   
       
      
. Where normalized RE results are given in table 4. 
 
Fig 16. Normalized central dose as a function of the air gap. Where experimental dose values are the ones 
extracted from RC films.  
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Table 4. Experimental RE results obtained from measurement. 
d (cm) 4.9 6.4 7.9 9.4 10.9 
RE (%) 100 86 82 85 72 
It can be seen that RE decreases until 72%, showing a notable quenching effect as it was 
predicted by the theoretical calculation made in section 4.3.2. In order to describe the effect 
correctly, a thorough study is needed. A whole analysis, including further irradiations, is 
being prepared and will be published in a peer-reviewed article. 
5. CONCLUSION 
The dosimetry conducted in this work, employing radiochromic films for monitoring a 
preclinical FLASH protontherapy experiment, has produced a number of results. On one 
hand, RC films utilized for measuring the doses received by cellular were slightly different 
between FLASH and conventional irradiation. Further analysis must be conducted in order to 
interpret the biological results (toxicity, proliferation) of the experiments.  
On the other hand, we conducted a study on the quenching effect on unlaminated EBT3 films 
for low-energy protons. Application of existing results to our setup predicts that radiochromic 
films, employed for monitoring 3 MeV protons, are subject to lower relative efficiencies in 
the proximity of Bragg peak. This effect must be characterized carefully in order to use RC 
films for absolute dosimetry. This highlights also the importance of knowing with great 
accuracy the position (i.e. the amount of air) of the samples, relative to the beam exit window. 
In addition, the quenching effect has been experimentally proved from the conducted beam 
profile measures. As dose values were obtained as a function of the distance between the film 
and the beam exit, this group of values was compared with the ones obtained from a Monte 
Carlo simulation and a dose underestimation was observed in experimental values. The 
measured RE values follow the same tendency as the (few) values from the literature, but our 
data suggest that the effect might be larger than has been published so far. This calls for 
further experiments, which will be soon performed.  
On the whole, radiochromic films can be utilized for FLASH and conventional irradiations 
dosimetry whenever quenching effect is taken into account when high LET particles are 
employed. Furthermore, after the made bibliographic research about the current state of 
FLASH radiotherapy, it can be concluded that it is a technique whose potential as a future 
treatment against cancer is promising. And in order to make possible that the great advantages 
offered by this radiotherapy technique can be applied to the clinical ambit, further 
investigation is needed. 
  
 
23 
 
6. BIBLIOGRAPHY 
Beyreuther, E., Brand, M., Hans, S., Hideghéty, K., Karsch, L., Leßmann, E., ... & Pawelke, J. (2019). 
Feasibility of proton FLASH effect tested by zebrafish embryo irradiation. Radiotherapy and Oncology, 139, 46-
50. 
Bourhis, J., Montay-Gruel, P., Jorge, P. G., Bailat, C., Petit, B., Ollivier, J., ... & Germond, J. F. (2019). Clinical 
translation of FLASH radiotherapy: Why and how?. Radiotherapy and Oncology, 139, 11-17. 
Bourhis, J., Sozzi, W. J., Jorge, P. G., Gaide, O., Bailat, C., Duclos, F., ... & Moeckli, R. (2019). Treatment of a 
first patient with FLASH-radiotherapy. Radiotherapy and oncology, 139, 18-22. 
Buonanno, M., Grilj, V., & Brenner, D. J. (2019). Biological effects in normal cells exposed to FLASH dose rate 
protons. Radiotherapy and Oncology, 139, 51-55. 
Das, I. J. (Ed.). (2017). Radiochromic film: role and applications in radiation dosimetry. CRC Press. 
Dewey, D. L. (1969). An oxygen-dependent X-ray dose-rate effect in Serratia marcescens. Radiation 
research, 38(3), 467-474. 
Favaudon, V., Caplier, L., Monceau, V., Pouzoulet, F., Sayarath, M., Fouillade, C., ... & Hall, J. (2014). 
Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in 
mice. Science translational medicine, 6(245), 245ra93-245ra93. 
Grilj, V., & Brenner, D. J. (2018). LET dependent response of GafChromic films investigated with MeV ion 
beams. Physics in Medicine & Biology, 63(24), 245021. 
Jaccard, M., Petersson, K., Buchillier, T., Germond, J. F., Durán, M. T., Vozenin, M. C., ... & Bailat, C. (2017). 
High dose‐per‐pulse electron beam dosimetry: Usability and dose‐rate independence of EBT3 Gafchromic 
films. Medical physics, 44(2), 725-735. 
Micke, A., Lewis, D. F., & Yu, X. (2011). Multichannel film dosimetry with nonuniformity correction. Medical 
physics, 38(5), 2523-2534. 
Montay-Gruel, P., Acharya, M. M., Petersson, K., Alikhani, L., Yakkala, C., Allen, B. D., ... & Nguyen, T. A. 
(2019). Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen 
species. Proceedings of the National Academy of Sciences, 116(22), 10943-10951. 
Montay-Gruel, P., Bouchet, A., Jaccard, M., Patin, D., Serduc, R., Aim, W., ... & Bräuer-Krisch, E. (2018). X-
rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury 
after whole brain irradiation in mice. Radiotherapy and Oncology, 129(3), 582-588. 
Montay-Gruel, P., Petersson, K., Jaccard, M., Boivin, G., Germond, J. F., Petit, B., ... & Bourhis, J. (2017). 
Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 
Gy/s. Radiotherapy and Oncology, 124(3), 365-369. 
Pratx, G., & Kapp, D. S. (2019). A computational model of radiolytic oxygen depletion during FLASH 
irradiation and its effect on the oxygen enhancement ratio. Physics in Medicine & Biology, 64(18), 185005. 
Reinhardt, S., Würl, M., Greubel, C., Humble, N., Wilkens, J. J., Hillbrand, M., ... & Parodi, K. (2015). 
Investigation of EBT2 and EBT3 films for proton dosimetry in the 4–20 MeV energy range. Radiation and 
environmental biophysics, 54(1), 71-79. 
Vozenin, M. C., De Fornel, P., Petersson, K., Favaudon, V., Jaccard, M., Germond, J. F., ... & Bouchaab, H. 
(2019). The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients. Clinical Cancer 
Research, 25(1), 35-42. 
